United States Pharmaceuticals

Evofem Biosciences Inc (EVFM)

Track

Ticker: EVFM Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Evofem Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 12 Jan 2024
Value US$4,187,880.31 | Price 494.43 | Shares 24,012 (+24.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-12 2024-01-12 S Sale
3.3
Zhang Yan

CFO

Officer
24,012 +24.8%
494.43
US$4,187,880 		24,012 +24.8% 494.43 US$4,187,880
2023-12-22 2023-12-21 S Sale
3.9
Kamdar Kim P.
Non-Executive Director
90,291 -6.0%
108.29
US$3,674,013 		90,291 -6.0% 108.29 US$3,674,013
2022-05-31 2022-05-27 B Purchase
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
99,540 -21.3%
319.27
US$2,961,456 		99,540 -21.3% 319.27 US$2,961,456
2021-12-20 2021-12-20 B Purchase
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
135,000 +15.9%
0.38
US$50,625 		135,000 +15.9% 0.38 US$50,625
2021-12-20 2021-12-20 B Purchase
3.3
Fitzpatrick Alexander A

General Counsel and Secretary

Officer
25,000 +8.0%
0.39
US$9,725 		25,000 +8.0% 0.39 US$9,725
2021-12-20 2021-12-20 B Purchase
2.6
File Justin J.

Chief Financial Officer

Officer
40,594 +9.2%
0.37
US$15,020 		40,594 +9.2% 0.37 US$15,020
2021-06-21 2021-06-18 B Purchase
3.9
Kamdar Kim P.
Non-Executive Director
10,000 +107.7%
1.17
US$11,650 		10,000 +107.7% 1.17 US$11,650
2021-06-14 2021-06-14 B Purchase
0.5
O'Brien Anthony Stephen
Non-Executive Director
8,140 +inf%
1.31
US$10,663 		8,140 +inf% 1.31 US$10,663
2021-06-14 2021-06-11 B Purchase
1.2
Rarick Lisa Dale
Non-Executive Director
5,000 +95.2%
1.20
US$5,990 		5,000 +95.2% 1.20 US$5,990
2021-06-11 2021-06-11 B Purchase
2.9
Barrans Russell

Chief Commercial Officer

Officer
18,180 +4.0%
1.14
US$20,725 		18,180 +4.0% 1.14 US$20,725
2021-06-10 2021-06-10 B Purchase
3.3
Fitzpatrick Alexander A

General Counsel and Secretary

Officer
10,000 +3.3%
1.03
US$10,250 		10,000 +3.3% 1.03 US$10,250
2021-06-10 2021-06-10 B Purchase
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
50,000 +6.2%
1.03
US$51,500 		50,000 +6.2% 1.03 US$51,500
2021-06-10 2021-06-10 B Purchase
2.6
File Justin J.

Chief Financial Officer

Officer
24,500 +5.9%
1.03
US$25,235 		24,500 +5.9% 1.03 US$25,235
2021-03-09 2021-03-09 PP Planned purchase
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
45,249 +5.3%
2.28
US$103,168 		45,249 +5.3% 2.28 US$103,168
2020-11-18 2020-11-17 B Purchase
2.6
File Justin J.

Chief Financial Officer

Officer
7,760 +3.1%
2.17
US$16,839 		7,760 +3.1% 2.17 US$16,839
2020-11-18 2020-11-17 B Purchase
3.3
Fitzpatrick Alexander A

General Counsel and Secretary

Officer
9,090 +6.8%
2.20
US$19,998 		9,090 +6.8% 2.20 US$19,998
2020-09-11 2020-09-11 B Purchase
2.9
Barrans Russell

Chief Commercial Officer

Officer
3,000 +1.1%
2.08
US$6,240 		3,000 +1.1% 2.08 US$6,240
2020-09-11 2020-09-10 B Purchase
2.9
Barrans Russell

Chief Commercial Officer

Officer
1,000 +0.4%
2.71
US$2,710 		1,000 +0.4% 2.71 US$2,710
2020-09-10 2020-09-08 S Sale
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
122,500 -25.3%
3.26
US$399,350 		122,500 -25.3% 3.26 US$399,350
2020-06-18 2020-06-17 B Purchase
1.2
Rarick Lisa Dale
Non-Executive Director
5,250 +inf%
2.99
US$15,698 		5,250 +inf% 2.99 US$15,698
2020-06-17 2020-06-15 B Purchase
2.0
Hall William Walmsley
Non-Executive Director
5,000 +inf%
2.85
US$14,250 		5,000 +inf% 2.85 US$14,250
2020-06-16 2020-06-12 B Purchase
3.9
Kamdar Kim P.
Non-Executive Director Large shareholder
5,000 +116.6%
2.94
US$14,700 		5,000 +116.6% 2.94 US$14,700
2020-06-15 2020-06-12 B Purchase
2.6
File Justin J.

Chief Financial Officer

Officer
8,500 +3.5%
3.14
US$26,690 		8,500 +3.5% 3.14 US$26,690
2020-06-09 2020-06-05 B Purchase
2.1
Invesco Ltd.
Large shareholder
857,143 +6.9%
3.50
US$3,000,000 		857,143 +6.9% 3.50 US$3,000,000
2020-07-17 2020-06-04 S Sale
Link Fund Solutions Ltd
Large shareholder
9,138,504 -100.0%
0.23
US$2,101,856 		9,138,504 -100.0% 0.23 US$2,101,856
2020-06-09 2020-06-04 S Sale
2.6
ACACIA RESEARCH CORP
Large shareholder
9,138,504 -100.0%
3.21
US$29,325,459 		9,138,504 -100.0% 3.21 US$29,325,459
2020-06-09 2020-05-26 S Sale
2.1
Invesco Ltd.
Large shareholder
65 -0.0%
5.98
US$389 		65 -0.0% 5.98 US$389
2020-06-09 2020-05-26 S Sale
2.1
Invesco Ltd.
Large shareholder
73,814 -0.6%
5.79
US$427,383 		73,814 -0.6% 5.79 US$427,383
2020-06-09 2020-05-15 S Sale
2.1
Invesco Ltd.
Large shareholder
3,211 -0.0%
5.04
US$16,183 		3,211 -0.0% 5.04 US$16,183
2020-05-01 2020-05-01 PlS Planned sale
3.3
Culwell Kelly

Chief Medical Officer

Officer
1,000 -0.5%
4.75
US$4,750 		1,000 -0.5% 4.75 US$4,750
2020-05-01 2020-04-30 PlS Planned sale
3.3
Culwell Kelly

Chief Medical Officer

Officer
1,000 -0.5%
4.66
US$4,660 		1,000 -0.5% 4.66 US$4,660
2020-02-21 2020-02-19 PlS Planned sale
3.3
Culwell Kelly

Chief Medical Officer

Officer
1,000 -0.5%
7.00
US$7,000 		1,000 -0.5% 7.00 US$7,000
2020-02-21 2020-02-19 PlS Planned sale
2.9
Barrans Russell

Chief Commercial Officer

Officer
14,957 -4.3%
6.50
US$97,220 		14,957 -4.3% 6.50 US$97,220
2020-01-21 2020-01-16 PlS Planned sale
2.9
Barrans Russell

Chief Commercial Officer
1,578 -0.8%
6.50
US$10,257 		1,578 -0.8% 6.50 US$10,257
2020-01-15 2020-01-13 PlS Planned sale
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
3,295 -0.9%
6.00
US$19,770 		3,295 -0.9% 6.00 US$19,770
2020-01-15 2020-01-13 PlS Planned sale
2.6
File Justin J.

Chief Financial Officer
1,648 -0.9%
6.00
US$9,888 		1,648 -0.9% 6.00 US$9,888
2020-01-06 2020-01-02 PlS Planned sale
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
6,705 -1.8%
6.05
US$40,565 		6,705 -1.8% 6.05 US$40,565
2020-01-06 2020-01-02 PlS Planned sale
2.6
File Justin J.

Chief Financial Officer
3,352 -1.8%
6.05
US$20,280 		3,352 -1.8% 6.05 US$20,280
2019-12-04 2019-12-02 PlS Planned sale
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
20,000 -5.1%
7.30
US$146,000 		20,000 -5.1% 7.30 US$146,000
2019-12-04 2019-12-02 PlS Planned sale Culwell Kelly

Chief Medical Officer

Officer
1,000 -2.2%
7.35
US$7,350 		1,000 -2.2% 7.35 US$7,350
2019-12-04 2019-12-02 PlS Planned sale
2.6
File Justin J.

Chief Financial Officer

Officer
10,000 -5.2%
7.16
US$71,600 		10,000 -5.2% 7.16 US$71,600
2019-11-21 2019-11-21 PlS Planned sale
2.6
File Justin J.

Chief Financial Officer

Officer
4,900 -2.4%
6.00
US$29,400 		4,900 -2.4% 6.00 US$29,400
2019-11-21 2019-11-21 PlS Planned sale PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
10,000 -2.4%
6.01
US$60,100 		10,000 -2.4% 6.01 US$60,100
2019-11-21 2019-11-20 PlS Planned sale
2.6
File Justin J.

Chief Financial Officer

Officer
100 -0.0%
6.00
US$600 		100 -0.0% 6.00 US$600
2019-06-12 2019-06-10 B Purchase
2.1
Invesco Ltd.
Large shareholder
2,222,222 +23.2%
4.50
US$9,999,999 		2,222,222 +23.2% 4.50 US$9,999,999
2019-06-10 2019-06-10 B Purchase
0.5
PDL BIOPHARMA, INC.
Large shareholder
6,666,667 +100.0%
4.50
US$30,000,002 		6,666,667 +100.0% 4.50 US$30,000,002
2019-05-23 2019-05-21 S Sale
3.9
Kamdar Kim P.
655 -100.0%
5.07
US$3,321 		655 -100.0% 5.07 US$3,321
2019-02-12 2019-02-08 B Purchase
2.1
Invesco Ltd.
Large shareholder
425,531 +4.6%
2.64
US$1,123,402 		425,531 +4.6% 2.64 US$1,123,402
2018-11-26 2018-11-21 B Purchase Barrans Russell

Chief Commercial Officer

Officer
279 +2.2%
3.55
US$990 		279 +2.2% 3.55 US$990
2018-08-21 2018-08-21 B Purchase
3.3
Fitzpatrick Alexander A

General Counsel and Secretary

Officer
500 +0.7%
2.27
US$1,135 		500 +0.7% 2.27 US$1,135
2018-08-21 2018-08-20 B Purchase
3.3
Fitzpatrick Alexander A

General Counsel and Secretary

Officer
4,500 +6.4%
2.20
US$9,900 		4,500 +6.4% 2.20 US$9,900
2018-08-20 2018-08-16 B Purchase
3.3
Culwell Kelly

Chief Medical Officer

Officer
3,000 +33.4%
2.24
US$6,720 		3,000 +33.4% 2.24 US$6,720
2018-08-15 2018-08-15 B Purchase Lynch Thomas G Non-Executive Director
68,929 +65.0%
2.33
US$160,605 		68,929 +65.0% 2.33 US$160,605
2018-08-15 2018-08-14 B Purchase Lynch Thomas G Non-Executive Director
31,071 +41.4%
2.10
US$65,249 		31,071 +41.4% 2.10 US$65,249
2018-08-13 2018-08-10 B Purchase
2.9
Barrans Russell

Chief Commercial Officer

Officer
3,715 +42.1%
1.98
US$7,356 		3,715 +42.1% 1.98 US$7,356
2018-08-13 2018-08-10 B Purchase
3.3
PELLETIER SAUNDRA L

Chief Executive Officer

Executive Director
10,000 +3.0%
2.11
US$21,100 		10,000 +3.0% 2.11 US$21,100
2018-05-24 2018-05-22 B Purchase Invesco Ltd. Large shareholder
2,127,659 +30.2%
4.69
US$9,978,721 		2,127,659 +30.2% 4.69 US$9,978,721
2015-12-30 2015-12-30 S Sale Alta Partners VIII, L.P.

Former 10% Owner
250,000 -15.7%
1.44
US$360,000 		250,000 -15.7% 1.44 US$360,000
2015-12-30 2015-12-29 S Sale Alta Partners VIII, L.P.

Former 10% Owner
493,654 -23.7%
1.53
US$755,291 		493,654 -23.7% 1.53 US$755,291
2015-12-30 2015-12-28 S Sale Alta Partners VIII, L.P.

Former 10% Owner
54,333 -2.5%
1.59
US$86,389 		54,333 -2.5% 1.59 US$86,389
2015-12-17 2015-12-15 S Sale Alta Partners VIII, L.P. Large shareholder
529,261 -19.8%
1.44
US$762,136 		529,261 -19.8% 1.44 US$762,136
2015-11-19 2015-11-18 PlS Planned sale
Locke Kenneth W

Chief Scientific Officer

Officer
6,098 -95.4%
8.30
US$50,619 		6,098 -95.4% 8.30 US$50,619
2015-09-22 2015-09-18 PlS Planned sale
Kemmerer Christopher

VP, Pharma Dev & Manufacturing

Officer
1,000 -8.4%
12.20
US$12,195 		1,000 -8.4% 12.20 US$12,195
2015-09-03 2015-09-01 PlS Planned sale Knudson Susan A.

Chief Financial Officer

Officer
3,000 -85.9%
11.33
US$33,990 		3,000 -85.9% 11.33 US$33,990
2015-08-10 2015-08-07 PlS Planned sale
Kemmerer Christopher

VP, Pharma Dev & Manufacturing

Officer
1,000 -8.4%
12.88
US$12,880 		1,000 -8.4% 12.88 US$12,880
2015-03-20 2015-03-19 B Purchase
1.8
Mahaffey George W

President and CEO

Executive Director
1,000 +0.5%
7.76
US$7,757 		1,000 +0.5% 7.76 US$7,757
2014-11-26 2014-11-25 B Purchase DOMAIN PARTERS VII L P Large shareholder
70,000 +2.3%
14.00
US$980,000 		70,000 +2.3% 14.00 US$980,000
2014-11-25 2014-11-25 B Purchase Gorbachev Maxim Non-Executive Director Large shareholder
70,000 +4.6%
14.00
US$980,000 		70,000 +4.6% 14.00 US$980,000
2014-11-25 2014-11-25 B Purchase RMI Investments S.a.r.l. Large shareholder
70,000 +4.6%
14.00
US$980,000 		70,000 +4.6% 14.00 US$980,000
2014-11-25 2014-11-25 B Purchase
JANNEY DANIEL
Non-Executive Director Large shareholder
70,000 +2.7%
14.00
US$980,000 		70,000 +2.7% 14.00 US$980,000
2014-11-25 2014-11-25 S Sale
JANNEY DANIEL
Non-Executive Director Large shareholder
21,429 -0.8%
14.00
US$300,006 		21,429 -0.8% 14.00 US$300,006
2014-11-25 2014-11-25 S Sale
JANNEY DANIEL
Non-Executive Director Large shareholder
70,714 -2.7%
14.00
US$989,996 		70,714 -2.7% 14.00 US$989,996
2014-11-25 2014-11-25 S Sale JANNEY DANIEL Non-Executive Director Large shareholder
57,143 -2.2%
14.00
US$800,002 		57,143 -2.2% 14.00 US$800,002
Explore more

More insider trading research around Evofem Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America